BDBM703771 N-[(2-chlorophen- yl)-methyl]-N-[2- ethyl-4-oxo-3-[[1- [2-(2H-tetrazol-5- yl)phenyl]-4-piper- idyl]methyl]quin- azolin-6-yl]thio- phene-2-carbox- amide::US20240368133, Compound A-248
SMILES CCc1nc2ccc(N(Cc3ccccc3Cl)C(=O)c3cccs3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1
InChI Key InChIKey=ZNQNVNHBGOBZQE-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 703771
TargetType-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor(Human)
Confo Therapeutics
US Patent
Confo Therapeutics
US Patent
Affinity DataIC50: 48nMAssay Description:All synthesized ligands were evaluated in a radioligand assay by displacing 125I-[Sar1, Ile8]-Angiotensin II (Perkin Elmer, NEX248050UC) from human A...More data for this Ligand-Target Pair
Affinity DataIC50: 4.01E+4nMAssay Description:All synthesized ligands were evaluated in a radioligand assay by displacing 125I-[Sar1, Ile8]-Angiotensin II (Perkin Elmer, NEX248050UC) from human A...More data for this Ligand-Target Pair